Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application-Reference-Cited by-同舟云学术

Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application

Published:2024-08 Issue:8 Volume:113 Page:2093-2100
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Antonova Nataliia P.^ORCID,Vasina Daria V.^ORCID,Grigoriev Igor V.,Usachev Evgeny V.^ORCID,Aleshkin Andrey V.,Vorobev Aleksei M.^ORCID,Laishevtsev Aleksei I.^ORCID,Kapustin Andrey V.,Savinov Vasiliy A.,Anurova Mariia N.,Zackharova Anastasia A.,Remizov Timofey A.,Makarov Valentine V.,Yudin Sergey M.,Gushchin Vladimir A.

Publisher

Elsevier BV

Reference21 articles.

1. Advanced engineering of third-generation lysins and formulation strategies for clinical applications;De Maesschalck;Crit Rev Microbiol,2020

2. Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient;Jun;Antimicrob Agents Chemother,2014

3. Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers;Jun;Antimicrob Agents Chemother,2017

4. Discovering the potentials of four phage endolysins to combat gram-negative infections;Vasina;Front Microbiol,2021

5. Successful treatment of chronic staphylococcus aureus-related dermatoses with the topical endolysin Staphefekt SA.100: a report of 3 cases;Totté;Case Rep Dermatol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections;Journal of Biomedical Science;2024-07-24